Filing Flows › Neuronetics (STIM) › Q2 2026 › vs Q2 2025
Neuronetics (STIM) Q2 2026 vs Q2 2025 (year over year)
Neuronetics's revenue rose $3.5M (+9%) from $38.1M in Q2 2025 to $41.6M in Q2 2026. The biggest changes: Service +$3.9M (+17%); NeuroStar −$407K (-3%).
Neuronetics, Q2 2026: revenue $41.6M (+9% year over year), operating margin -3.6%, net loss $3.5M, operating cash flow −$1.0M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Service | $26.9M | $23.0M | $3.9M | +17% |
| NeuroStar | $14.7M | $15.1M | −$407K | -3% |
| Revenue | $41.6M | $38.1M | $3.5M | +9% |
| Net loss | $3.5M | $9.8M | −$6.4M | -65% |
| Costs & expenses | $45.0M | $47.9M | −$2.9M | -6% |
| Operating costs | $43.1M | $46.2M | −$3.1M | -7% |
| Interest & other, net | $2.0M | $1.8M | $182K | +10% |
| Cost of revenue | $20.3M | $20.4M | −$5K | 0% |
| Research & development | $1.3M | $1.8M | −$462K | -26% |
| Sales & marketing | $10.0M | $11.9M | −$1.9M | -16% |
| General & admin | $11.4M | $12.2M | −$746K | -6% |
| Operating cash sources | $3.5M | $9.8M | −$6.4M | -65% |
| Depreciation & amortization | $729K | $901K | −$172K | -19% |
| Share-based compensation | $688K | $1.8M | −$1.1M | -62% |
| Working capital & other | $1.0M | $3.6M | −$2.6M | -71% |
| Cash used in operations | $1.0M | $3.5M | −$2.5M | -71% |
| Net loss absorbed | $3.5M | $9.8M | −$6.4M | -65% |
Questions
How much did Neuronetics's revenue grow year over year in Q2 2026?
Neuronetics's revenue rose $3.5M (+9%) from $38.1M in Q2 2025 to $41.6M in Q2 2026.
What drove Neuronetics's revenue change in Q2 2026?
Service +$3.9M (+17%); NeuroStar −$407K (-3%).